Pharmalot Ed Silverman Will the European Union give vouchers to pharma to develop badly needed antibiotics?
Pharmalot Ed Silverman Pharmalittle: India regulator finds 5% of drug samples are substandard; EMA claims new clinical trial registry is fixed
Pharmalot Ed Silverman Pharmalittle: HIV vaccine study is stopped early; Merck has a plan to combat carcinogen found in diabetes drugs
Pharmalot Ed Silverman Major purchasers predict expensive new therapies will keep driving drug price hikes
Pharmalot Ed Silverman Pfizer says it will widen access to hundreds of off-patent medicines in low-income countries
Pharmalot Ed Silverman Pharmalittle: Lilly and AbbVie exit U.K. drug-pricing program; J&J scales back Covid-19 vaccine production
Pharmalot Ed Silverman Large health insurers lowered barriers to fair access to some drugs, analysis finds
First Opinion Daniel Eisenkraft Klein Stop blaming Biogen for putting profit at the expense of patients. Blame the systems that enabled it
Pharmalot Ed Silverman Pharmalittle: Pharma prioritizes biologics over pills due to drug-pricing law; former Takeda employee accused of creating fake consulting firm
Pharmalot Ed Silverman California is the latest state to sue drugmakers and PBMs over insulin pricing
Biotech Jonathan Saltzman — Boston Globe ‘We become millionaires and we retire babe’: Former Takeda worker and boyfriend accused of $2.3 million scam of drug firm
Pharmalot Ed Silverman Pharmalittle: HHS readying details for Medicare drug-price negotiations; doctors urge FDA to hold expert meeting before approving Alzheimer’s drug
Pharmalot Ed Silverman Physicians group urges FDA to convene expert panel before finally approving an Alzheimer’s drug
Pharmalot Ed Silverman Pharmalittle: Pfizer will not license generic Covid-19 pill in China; BioMarin signs outcomes-based deal in Germany for gene therapy
Pharmalot Ed Silverman Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug
Pharmalot Ed Silverman FDA scolds Sun Pharmaceutical for serious quality control problems at a key plant in India
Pharmalot Ed Silverman Pharmalittle: FDA increasingly pausing trials of experimental meds; FDA commish isn’t surprised by congressional report on Alzheimer’s drug
Pharmalot Ed Silverman Moderna plans to follow in Pfizer’s footsteps, charge up to $130 for Covid-19 vaccine in U.S.
Biotech Jonathan Wosen and Allison DeAngelis A flurry of pharma acquisitions kick off JPM week after a slow year for deals
Pharmalot Ed Silverman Pharmalittle: Pediatricians recommend obesity drugs for children; as JPM starts, industry execs have a gloomy financing outlook
Pharma Patrick Skerrett India’s lax oversight of pharmaceutical manufacturing imperils health around the world
Pharmalot Ed Silverman The FDA has approved a new Alzheimer’s drug, but wide access may depend on CMS easing restrictions
Biotech Adam Feuerstein FDA approves Alzheimer’s drug shown to moderately slow cognitive decline in early stages of the disease